BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 19307185)

  • 1. Cellular functions and X-ray structure of anthrolysin O, a cholesterol-dependent cytolysin secreted by Bacillus anthracis.
    Bourdeau RW; Malito E; Chenal A; Bishop BL; Musch MW; Villereal ML; Chang EB; Mosser EM; Rest RF; Tang WJ
    J Biol Chem; 2009 May; 284(21):14645-56. PubMed ID: 19307185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of anthrolysin O in gut epithelial barrier disruption during Bacillus anthracis infection.
    Bishop BL; Lodolce JP; Kolodziej LE; Boone DL; Tang WJ
    Biochem Biophys Res Commun; 2010 Apr; 394(2):254-9. PubMed ID: 20188700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cholesterol-dependent cytolysin signature motif: a critical element in the allosteric pathway that couples membrane binding to pore assembly.
    Dowd KJ; Farrand AJ; Tweten RK
    PLoS Pathog; 2012; 8(7):e1002787. PubMed ID: 22792065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural studies of Streptococcus pyogenes streptolysin O provide insights into the early steps of membrane penetration.
    Feil SC; Ascher DB; Kuiper MJ; Tweten RK; Parker MW
    J Mol Biol; 2014 Feb; 426(4):785-92. PubMed ID: 24316049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Bacillus anthracis cholesterol-dependent cytolysin, Anthrolysin O, kills human neutrophils, monocytes and macrophages.
    Mosser EM; Rest RF
    BMC Microbiol; 2006 Jun; 6():56. PubMed ID: 16790055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution imaging and quantification of plasma membrane cholesterol by NanoSIMS.
    He C; Hu X; Jung RS; Weston TA; Sandoval NP; Tontonoz P; Kilburn MR; Fong LG; Young SG; Jiang H
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2000-2005. PubMed ID: 28167768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time monitoring of the membrane-binding and insertion properties of the cholesterol-dependent cytolysin anthrolysin O from Bacillus anthracis.
    Cocklin S; Jost M; Robertson NM; Weeks SD; Weber HW; Young E; Seal S; Zhang C; Mosser E; Loll PJ; Saunders AJ; Rest RF; Chaiken IM
    J Mol Recognit; 2006; 19(4):354-62. PubMed ID: 16775845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthrolysin O and fermentation products mediate the toxicity of Bacillus anthracis to lung epithelial cells under microaerobic conditions.
    Popova TG; Millis B; Chung MC; Bailey C; Popov SG
    FEMS Immunol Med Microbiol; 2011 Feb; 61(1):15-27. PubMed ID: 20946354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. plcR papR-independent expression of anthrolysin O by Bacillus anthracis.
    Ross CL; Koehler TM
    J Bacteriol; 2006 Nov; 188(22):7823-9. PubMed ID: 16980467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of anthrolysin O, the Bacillus anthracis cholesterol-dependent cytolysin.
    Shannon JG; Ross CL; Koehler TM; Rest RF
    Infect Immun; 2003 Jun; 71(6):3183-9. PubMed ID: 12761097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific protein-membrane contacts are required for prepore and pore assembly by a cholesterol-dependent cytolysin.
    Soltani CE; Hotze EM; Johnson AE; Tweten RK
    J Biol Chem; 2007 May; 282(21):15709-16. PubMed ID: 17412689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of perfringolysin O suggest a pathway for activation of cholesterol-dependent cytolysins.
    Rossjohn J; Polekhina G; Feil SC; Morton CJ; Tweten RK; Parker MW
    J Mol Biol; 2007 Apr; 367(5):1227-36. PubMed ID: 17328912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracis.
    Cowan GJ; Atkins HS; Johnson LK; Titball RW; Mitchell TJ
    Vaccine; 2007 Oct; 25(41):7197-205. PubMed ID: 17765365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol-dependent cytolysins.
    Gilbert RJ
    Adv Exp Med Biol; 2010; 677():56-66. PubMed ID: 20687480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of human specific cytolysin intermedilysin aiming application to cancer immunotherapy.
    Ohkura K; Nagamune H; Kourai H
    Anticancer Res; 2004; 24(5C):3343-53. PubMed ID: 15515430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of cytotoxin protein suilysin from Streptococcus suis.
    Xu L; Huang B; Du H; Zhang XC; Xu J; Li X; Rao Z
    Protein Cell; 2010 Jan; 1(1):96-105. PubMed ID: 21204001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthrolysin O and other gram-positive cytolysins are toll-like receptor 4 agonists.
    Park JM; Ng VH; Maeda S; Rest RF; Karin M
    J Exp Med; 2004 Dec; 200(12):1647-55. PubMed ID: 15611291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Basis for Receptor Recognition by the Human CD59-Responsive Cholesterol-Dependent Cytolysins.
    Lawrence SL; Gorman MA; Feil SC; Mulhern TD; Kuiper MJ; Ratner AJ; Tweten RK; Morton CJ; Parker MW
    Structure; 2016 Sep; 24(9):1488-98. PubMed ID: 27499440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Structural Basis for a Transition State That Regulates Pore Formation in a Bacterial Toxin.
    Wade KR; Lawrence SL; Farrand AJ; Hotze EM; Kuiper MJ; Gorman MA; Christie MP; Panjikar S; Morton CJ; Parker MW; Tweten RK
    mBio; 2019 Apr; 10(2):. PubMed ID: 31015325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cholesterol-dependent Cytolysin Membrane-binding Interface Discriminates Lipid Environments of Cholesterol to Support β-Barrel Pore Insertion.
    Farrand AJ; Hotze EM; Sato TK; Wade KR; Wimley WC; Johnson AE; Tweten RK
    J Biol Chem; 2015 Jul; 290(29):17733-17744. PubMed ID: 26032415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.